Feds Get Rare ‘Gas Station Heroin’ Conviction
A California man has been convicted of smuggling and misbranding tianeptine after selling the unapproved drug as a “mood enhancer.” By Manisha Krishnan September 13, 2023 A California man has […]
Entries by admin_fidj
Florida Litigation Procedure Update: Third DCA Clarifies Key Aspects of § 57.105
In AT&T Mobility, LLC v. Rigney, 3D21-2261 (Fla. 3d DCA Sept. 6, 2023), Florida’s Third District Court of Appeal reviewed the denial of two motions for sanctions under section 57.105, […]
Federal Litigation Update: The Eleventh Circuit Clarifies When Expert Reports are Required by Fed. R. Civ. P. 26(a)(2)(B).
On August 4, 2023, in Cedant v. United States, No. 21-12661, –F.4th–, 2023 WL 4986402 (11th Cir. August 4, 2023), the Eleventh Circuit clarified who must provide expert reports under Fed. R. Civ. P. 26(a)(2)(B).
Eleventh Circuit Court of Appeals:
On March 9, 2022, the Eleventh Circuit Court of Appeals denied a petition for permission to appeal an order remanding a case removed to federal court under the Class Action […]
Florida Supreme Court
On February 3, 2022, the Florida Supreme Court issued its opinion in Pincus v. American Traffic Solutions, Inc. clarifying that under Florida law, where a plaintiff has received adequate consideration […]
Florida Appellate Practice Update:
On January 6, 2022, the Florida Supreme Court started the new year off with a bang, to wit: the Court amended Florida Rule of Appellate Procedure 9.130 to allow for […]
Realtors’ tip: If you want that house, come with cash.
In South Florida’s super-charged real estate market, cash gives buyers a leg up — and those offers are rising faster than the newest condo buildings in Brickell.
Strengthening the Stem Cell Industry Through Better Regulation
By Andrew Ittleman April 06, 2021 After Congress adopted the 21st Century Cures Act in 2016, giving the U.S. Food and Drug Administration (FDA) authority to streamline the approval process for qualifying regenerative medicine advanced […]
Miami Lawyer Leads Startup’s COVID-19 Screening Device to FDA Approval
A first-of-its-kind screening device for identifying COVID-19 biomarkers has secured emergency approval from the U.S. Food and Drug Administration, with the help of Miami’s Fuerst Ittleman founding partner Andrew S. Ittleman.
AML Compliance Game Changer:
Part II of this series focuses on the Corporate Disclosure Act.
